Quick Answer
ENANTA PHARMACEUTICALS INC reported Research And Development Expense of $106.74 million for the year ending 2025.
- ENANTA PHARMACEUTICALS INC showed a decrease of -18.8% in Research And Development Expense from 2024 to 2025.
- This data is from ENANTA PHARMACEUTICALS INC's annual report (Form 10-K), filed with the SEC on November 19, 2025.
- XBRL data for this metric is available from 2011 to 2025 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 15 years of available data (2011 to 2025), ENANTA PHARMACEUTICALS INC's Research And Development Expense has grown by 824.4%.
- Historical annual values: Fiscal year 2025: $106.74 million | Fiscal year 2024: $131.48 million | Fiscal year 2023: $163.52 million | Fiscal year 2022: $164.52 million | Fiscal year 2021: $174.11 million | Fiscal year 2020: $136.76 million | Fiscal year 2019: $142.21 million | Fiscal year 2018: $94.86 million | Fiscal year 2017: $57.45 million | Fiscal year 2016: $40.46 million | Fiscal year 2015: $23.19 million | Fiscal year 2014: $18.74 million | Fiscal year 2013: $16.84 million | Fiscal year 2012: $15.12 million | Fiscal year 2011: $11.55 million.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: